本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

福泰製藥

421.67
-4.3300-1.02%
盤後422.941.27+0.30%19:55 EST
成交量:236.55萬
成交額:9.99億
市值:1,081.12億
市盈率:29.97
高:430.71
開:418.55
低:403.16
收:426.00
52周最高:519.88
52周最低:362.50
股本:2.56億
流通股本:2.56億
量比:1.64
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):14.07
每股收益(LYR):-2.0768
淨資產收益率:22.77%
總資產收益率:12.53%
市淨率:6.29
市盈率(LYR):-203.04

資料載入中...

2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities